CANF Can-Fite BioPharma Ltd. ADRs

Can Fite Biofarma Ltd is a clinical stage biopharmaceutical company. It develops orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:CFBI.

$2.14  -0.03 (-1.38%)
As of 06/22/2021 15:06:34 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  Israel
IPO date:  11/01/2012
Outstanding shares:  17,191,543
Average volume:  746,700
Market cap:   $39,196,718
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    13471N102
ISIN:        US13471N1028
Valuation   (See tab for details)
PE ratio:   -3.31
PB ratio:   5.17
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy